Acquisitions30 Oct 2025, 05:21 pm
Orchid Pharma Ltd Completes Purchase of Assets from Allecra Therapeutics GmbH
AI Summary
Orchid Pharma Ltd has successfully completed the purchase of all assets from Allecra Therapeutics GmbH. The transaction, which was initially announced on July 30, 2025, was finalized on October 29, 2025, following the completion of all conditions precedent. As a result of this acquisition, Orchid now owns all of Allecra's intellectual property and commercial contracts.
Key Highlights
- Orchid Pharma Ltd completes the purchase of Allecra Therapeutics GmbH's assets
- Transaction finalized on October 29, 2025
- Orchid now owns all of Allecra's intellectual property and commercial contracts
- Completion follows the fulfillment of all conditions precedent
- Acquisition strengthens Orchid's portfolio and capabilities